NeuroPace Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NeuroPace, Inc. (NPCE) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-27.14-32.96-47.08-36.08-24.28
Depreciation & Amortization1.771.613.280.300.31
Stock Based Compensation10.289.568.354.291.38
Change in Working Capital-5.45-2.48-2.680.37-2.07
Change in Accounts Receivable-0.54-4.85-0.391.30-2.38
Change in Inventory0.25-1.70-2.13-1.160.67
Change in Accounts Payable0.670.240.650.480.00
Change in Other Working Capital-5.842.733.071.07-0.36
Other Operating Activities2.593.989.251.07-0.46
Net Cash from Operating Activities-17.95-19.70-36.87-24.58-21.61
Investing Activities
Capital Expenditures-0.31-0.170.60-0.38-0.06
Purchases of Investments0.0023.2024.40-85.01-10.71
Sales/Maturities of Investments9.3023.2024.40-85.010.00
Net Cash from Investing Activities8.9923.0323.80-85.40-10.77
Financing Activities
Debt Repayment0.000.000.00-4.090.00
Common Stock Issued3.288.69-0.35109.090.01
Common Stock Repurchased0.00-0.26-0.060.000.00
Other Financing Activities1.05-0.31-0.06-3.39-1.16
Net Cash from Financing Activities4.338.130.49102.5355.01
Summary
Net Change in Cash-4.6311.45-12.58-7.4522.63
Cash at Beginning of Period18.186.7319.3126.760.00
Cash at End of Period13.55-19.846.7319.310.00
Free Cash Flow-18.26-19.87-37.50-24.96-21.67
Supplemental Disclosures
Interest Paid6.234.484.466.344.41